FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used for prediction of improvement of left ventricular diastolic function after sympathetic denervation of renal arteries. Before the intervention, patient undergoes 24-hour blood pressure monitoring and the daily systolic blood pressure index is assessed using a mathematical algorithm for determining the period of night sleep based on heart rate monitoring data. If the daily systolic blood pressure index is 5.5% and less, the improvement of diastolic function of the left ventricle is predicted 6 months after the procedure.
EFFECT: method enables optimizing the selection of patients with resistant arterial hypertension combined with type 2 diabetes for the procedure of renal denervation by assessing the aggregate of the most significant parameters.
1 cl, 1 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING IMPROVEMENT OF RENAL HEMODYNAMICS 6 MONTHS AFTER PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2807270C1 |
| METHOD OF SELECTION OF PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION FOR CONDUCTING THE PROCEDURE OF SYMPATHETIC DENERVATION OF RENAL ARTERIES | 2017 |
|
RU2658476C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE PROCEDURE OF SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION COMBINED WITH TYPE 2 DIABETES MELLITUS | 2021 |
|
RU2772544C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF NEPHROPROTECTION IN SELECTING THE PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS FOR THE SYMPATHETIC RENAL DENERVATION OF RENAL ARTERIES | 2019 |
|
RU2728093C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE RENAL DENERVATION PROCEDURE FOR THE SELECTION OF PATIENTS WITH ARTERIAL HYPERTENSION RESISTANT TO DRUG THERAPY IN ITS IMPLEMENTATION | 2020 |
|
RU2750023C1 |
| METHOD FOR TREATING PATIENTS WITH ISCHEMIC CARDIAC DISEASE, STABLE STENOCARDIA IN COMBINATION WITH ARTERIAL HYPERTENSION | 2005 |
|
RU2294741C1 |
| METHOD FOR CORRECTION OF CRISIS COURSE OF HYPERTENSIVE DISEASE AND ABDOMINAL OBESITY | 2013 |
|
RU2542462C2 |
| METHOD OF DIFFERENTIATED ADMINISTRATION OF MOXONIDINE IN PATIENTS WITH ARTERIAL HYPERTENSION AT BACKGROUND OF METABOLIC SYNDROME | 2010 |
|
RU2426543C1 |
| METHOD FOR PREDICTING THE LONG-TERM ANTIHYPERTENSIVE EFFICACY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION | 2021 |
|
RU2767134C1 |
| METHOD FOR EVALUATING CLINICAL THERAPEUTIC EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2006 |
|
RU2316996C1 |
